Urocortins: emerging metabolic and energy homeostasis perspectives

Trends in Endocrinology and Metabolism

Volumn 19, Issue 4, 2008, Pages 122-129

  Kuperman, Yael ^a   Chen, Alon ^a  

^a WEIZMANN INSTITUTE OF SCIENCE   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOTROPIN RELEASING FACTOR RECEPTOR 2; UROCORTIN; UROCORTIN II; UROCORTIN III;

AUTOCRINE EFFECT; ENERGY BALANCE; ENERGY METABOLISM; GLUCOSE HOMEOSTASIS; HUMAN; INSULIN RELEASE; INSULIN SENSITIVITY; NONHUMAN; PARACRINE SIGNALING; PRIORITY JOURNAL; PROTEIN FUNCTION; REVIEW; SKELETAL MUSCLE; STRESS;

ANIMALS; CORTICOTROPIN-RELEASING HORMONE; ENERGY METABOLISM; HOMEOSTASIS; HUMANS; INSULIN; INSULIN RESISTANCE; METABOLISM; MODELS, BIOLOGICAL; MUSCLE, SKELETAL; PANCREAS; RECEPTORS, CORTICOTROPIN-RELEASING HORMONE; STRESS; UROCORTINS;

EID: 42949157683     PISSN: 10432760     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tem.2007.12.002     Document Type: Review

References (58)

1. Vale W., et al. Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and beta-endorphin. Science 213 (1981) 1394-1397
2. Rivier C., and Vale W. Modulation of stress-induced ACTH release by corticotropin releasing factor, catecholamines and vasopressin. Nature 305 (1983) 325-327
3. Muglia L., et al. Corticotropin-releasing hormone deficiency reveals major fetal but not adult glucocorticoid need. Nature 373 (1995) 427-432
4. Sutton R.E., et al. Corticotropin-releasing factor (CRF) produces behavioral activation in rats. Nature 297 (1982) 331-333
5. Brown M.R., et al. Corticotropin-releasing factor (CRF): actions on the sympathetic nervous system and metabolism. Endocrinology 111 (1982) 928-931
6. Koob G.F., and Heinrichs S.C. A role for corticotropin releasing factor and urocortin in behavioral responses to stressors. Brain Res. 848 (1999) 141-152
7. 1 antagonists for anxiety. Expert Opin. Investig. Drugs 13 (2004) 799-828
8. Heinrichs S.C., and Koob G.F. Corticotropin-releasing factor in brain: a role in activation, arousal, and affect regulation. J. Pharmacol. Exp. Ther. 311 (2004) 427-440
9. Holsboer F. The rationale for corticotropin-releasing hormone receptor (CRH-R) antagonists to treat depression and anxiety. J. Psychiatr. Res. 33 (1999) 181-214
10. Arborelius L., et al. The role of corticotropin-releasing factor in depression and anxiety disorders. J. Endocrinol. 160 (1999) 1-12
11. Holmes A., et al. Neuropeptide systems as novel therapeutic targets for depression and anxiety disorders. Trends Pharmacol. Sci. 24 (2003) 580-588
12. Bale T.L. Sensitivity to stress: dysregulation of CRF pathways and disease development. Horm. Behav. 48 (2005) 1-10
13. Chrousos G.P., and Gold P.W. The concepts of stress and stress system disorders. Overview of physical and behavioral homeostasis. JAMA 267 (1992) 1244-1252
14. de Kloet E.R., et al. Stress and the brain: from adaptation to disease. Nat. Rev. Neurosci. 6 (2005) 463-475
15. McEwen B.S. Protection and damage from acute and chronic stress: allostasis and allostatic overload and relevance to the pathophysiology of psychiatric disorders. Ann. N. Y. Acad. Sci. 1032 (2004) 1-7
16. Vaughan J., et al. Urocortin, a mammalian neuropeptide related to fish urotensin I and to corticotropin-releasing factor. Nature 378 (1995) 287-292
17. Reyes T.M., et al. Urocortin II: a member of the corticotropin-releasing factor (CRF) neuropeptide family that is selectively bound by type 2 CRF receptors. Proc. Natl. Acad. Sci. U. S. A. 98 (2001) 2843-2848
18. Hsu S.Y., and Hsueh A.J. Human stresscopin and stresscopin-related peptide are selective ligands for the type 2 corticotropin-releasing hormone receptor. Nat. Med. 7 (2001) 605-611
19. Lewis K., et al. Identification of urocortin III, an additional member of the corticotropin-releasing factor (CRF) family with high affinity for the CRF2 receptor. Proc. Natl. Acad. Sci. U. S. A. 98 (2001) 7570-7575
20. Chen R., et al. Expression cloning of a human corticotropin releasing factor (CRF) receptor. Proc. Natl. Acad. Sci. U. S. A. 90 (1993) 8967-8971
21. Perrin M.H., et al. Cloning and functional expression of a rat brain corticotropin releasing factor (CRF) receptor. Endocrinology 133 (1993) 3058-3061
22. Vita N., et al. Primary structure and functional expression of mouse pituitary and human brain corticotrophin releasing factor receptors. FEBS Lett. 335 (1993) 1-5
23. Chang C.-P., et al. Identification of a seven transmembrane helix receptor for corticotropin-releasing factor and sauvagine in mammalian brain. Neuron 11 (1993) 1187-1195
24. Perrin M., et al. Identification of a second corticotropin-releasing factor receptor gene and characterization of a cDNA expressed in heart. Proc. Natl. Acad. Sci. U. S. A. 92 (1995) 2969-2973
25. Stenzel P., et al. Identification of a novel murine receptor for corticotropin-releasing hormone expressed in the heart. Mol. Endocrinol. 9 (1995) 637-645
26. Kishimoto T., et al. A sauvagine/corticotropin-releasing factor receptor expressed in heart and skeletal muscle. Proc. Natl. Acad. Sci. U. S. A. 92 (1995) 1108-1112
27. Lovenberg T.W., et al. Cloning and characterization of a functionally distinct corticotropin-releasing factor receptor subtype from rat brain. Proc. Natl. Acad. Sci. U. S. A. 92 (1995) 836-840
28. Van Pett K., et al. Distribution of mRNAs encoding CRF receptors in brain and pituitary of rat and mouse. J. Comp. Neurol. 428 (2000) 191-212
29. Kostich W.A., et al. Molecular identification and analysis of a novel human corticotropin-releasing factor (CRF) receptor: the CRF2γ receptor. Mol. Endocrinol. 12 (1998) 1077-1085
30. Potter E., et al. Cloning and characterization of the cDNAs for human and rat corticotropin releasing factor-binding proteins. Nature 349 (1991) 423-426
31. Chen A.M., et al. A soluble mouse brain splice variant of type 2α corticotropin-releasing factor (CRF) receptor binds ligands and modulates their activity. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 2620-2625
32. Dallman M.F., et al. Glucocorticoids, chronic stress, and obesity. Prog. Brain Res. 153 (2006) 75-105
33. Zorrilla E.P., et al. Nibbling at CRF receptor control of feeding and gastrocolonic motility. Trends Pharmacol. Sci. 24 (2003) 421-427
34. Richard D., et al. The corticotropin-releasing factor family of peptides and CRF receptors: their roles in the regulation of energy balance. Eur. J. Pharmacol. 440 (2002) 189-197
35. Perrin M.H., and Vale W.W. Corticotropin releasing factor receptors and their ligand family. Ann. N. Y. Acad. Sci. 885 (1999) 312-328
36. Dautzenberg F.M., and Hauger R.L. The CRF peptide family and their receptors: yet more partners discovered. Trends Pharmacol. Sci 23 (2002) 71-77
37. Chen A., et al. Urocortin 2-deficient mice exhibit gender-specific alterations in circadian hypothalamus-pituitary-adrenal axis and depressive-like behavior. J. Neurosci. 26 (2006) 5500-5510
38. Chen A., et al. Glucocorticoids regulate the expression of the mouse urocortin II gene: a putative connection between the corticotropin-releasing factor receptor pathways. Mol. Endocrinol. 17 (2003) 1622-1639
39. Chen A., et al. Urocortin II gene is highly expressed in mouse skin and skeletal muscle tissues: localization, basal expression in CRFR1 and CRFR2-null mice and regulation by glucocorticoids. Endocrinology 145 (2004) 2445-2457
40. Chen A., et al. Urocortin 2 modulates glucose utilization and insulin sensitivity in skeletal muscle. Proc. Natl. Acad. Sci. U. S. A. 103 (2006) 16580-16585
41. Li C., et al. Urocortin III-immunoreactive projections in rat brain: partial overlap with sites of type 2 corticotrophin-releasing factor receptor expression. J. Neurosci. 22 (2002) 991-1001
42. Jamieson P.M., et al. Urocortin 3 modulates the neuroendocrine stress response and is regulated in rat amygdala and hypothalamus by stress and glucocorticoids. Endocrinology 147 (2006) 4578-4588
43. Li C., et al. Urocortin III is expressed in pancreatic beta-cells and stimulates insulin and glucagon secretion. Endocrinology 144 (2003) 3216-3224
44. Li C., et al. Urocortin 3 regulates glucose-stimulated insulin secretion and energy homeostasis. Proc. Natl. Acad. Sci. U. S. A. 104 (2007) 4206-4211
45. Chen A., et al. Mouse corticotropin-releasing factor receptor type 2α gene: isolation, distribution, pharmacological characterization and regulation by stress and glucocorticoids. Mol. Endocrinol. 19 (2005) 441-458
46. Bale T.L., et al. Mice deficient for corticotropin-releasing hormone receptor-2 display anxiety-like behaviour and are hypersensitive to stress. Nat. Genet. 24 (2000) 410-414
47. Coste S.C., et al. Abnormal adaptations to stress and impaired cardiovascular function in mice lacking corticotropin-releasing hormone receptor-2. Nat. Genet. 24 (2000) 403-409
48. Kishimoto T., et al. Deletion of crhr2 reveals an anxiolytic role for corticotropin-releasing hormone receptor-2. Nat. Genet. 24 (2000) 415-419
49. Bale T.L., et al. Corticotropin-releasing factor receptor-2-deficient mice display abnormal homeostatic response to challenges of increased dietary fat and cold. Endocrinology 144 (2003) 2580-2587
50. Carlin K.M., et al. Vital functions of corticotropin-releasing factor (CRF) pathways in maintenance and regulation of energy homeostasis. Proc. Natl. Acad. Sci. U. S. A. 103 (2006) 3462-3467
51. Zorrilla E.P., et al. Human urocortin 2, a corticotropin-releasing factor (CRF)2 agonist, and ovine CRF, a CRF1 agonist, differentially alter feeding and motor activity. J. Pharmacol. Exp. Ther. 310 (2004) 1027-1034
52. Inoue K., et al. Human urocortin II, a selective agonist for the type 2 corticotropin-releasing factor receptor, decreases feeding and drinking in the rat. J. Pharmacol. Exp. Ther. 305 (2003) 385-393
53. Fekete E.M., et al. Delayed satiety-like actions and altered feeding microstructure by a selective type 2 corticotropin-releasing factor agonist in rats: intra-hypothalamic urocortin 3 administration reduces food intake by prolonging the post-meal interval. Neuropsychopharmacology 32 (2007) 1052-1068
54. Makino S., et al. Altered expression of type 2 CRH receptor mRNA in the VMH by glucocorticoids and starvation. Am. J. Physiol. 275 (1998) R1138-R1145
55. Makino S., et al. Decreased type 2 corticotrophin-releasing hormone receptor mRNA expression in the ventromedial hypothalamus during repeated immobilization stress. Neuroendocrinology 70 (1999) 160-167
56. McCrimmon R.J., et al. Corticotrophin-releasing factor receptors within the ventromedial hypothalamus regulate hypoglycemia-induced hormonal counterregulation. J. Clin. Invest. 116 (2006) 1723-1730
57. Cheng H., et al. Type 1 corticotrophin-releasing factor receptors (CRFR1) in the ventromedial hypothalamus (VMH) promote hypoglycemia-induced hormonal counterregulation. Am. J. Physiol. Endocrinol. Metab. 293 (2007) E705-E712
58. In: Paxinos G. (Ed). The rat Nervous System (2004), Elsevier Academic Press